Fridamycin A, a Microbial Natural Product, Stimulates Glucose Uptake without Inducing Adipogenesis

Type 2 diabetes is a complex, heterogeneous, and polygenic disease. Currently, available drugs for treating type 2 diabetes predominantly include sulfonylureas, α-glucosidase inhibitors, and biguanides. However, long-term treatment with these therapeutic drugs is often accompanied by undesirable sid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Sun-Young, Lee, Seoung Rak, Hwang, Ji Young, Benndorf, René, Beemelmanns, Christine, Chung, Sang J., Kim, Ki Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520714/
https://www.ncbi.nlm.nih.gov/pubmed/30939853
http://dx.doi.org/10.3390/nu11040765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520714/
https://www.ncbi.nlm.nih.gov/pubmed/30939853
http://dx.doi.org/10.3390/nu11040765

Ejemplares similares